| Name | Walgreens #9065 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 401 5th St W, Northfield, Minnesota 55057 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (507) 645-9658 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
› Verified 1 days ago
| NPI Number | 1922013150 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #09065 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 401 5th St W, Northfield, MN 55057 |
| Phone Number | 507-645-9658 |
News Archive
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
› Verified 1 days ago
News Archive
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.
› Verified 1 days ago
Sterling Type: Community/Retail Pharmacy Location: 700 Division S St, Northfield, Minnesota 55057 Phone: (507) 645-4455 | |
Northfield Pharmacy Type: Community/Retail Pharmacy Location: 601 Water St S, Northfield, Minnesota 55057 Phone: (507) 663-0344 | |
Cvs Pharmacy #16566 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2323 Highway 3 S, Northfield, Minnesota 55057 Phone: (507) 403-4014 | |
River Valley Eye Professionals Type: Eyewear Supplier (Equipment, not the service) Location: 2019 Jefferson Rd, Northfield, Minnesota 55057 Phone: (507) 645-9202 | |
Cub Pharmacy #1637 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2423 Highway 3 S, Northfield, Minnesota 55057 Phone: (507) 664-9029 |